Vadivelu Comedy News
Kushanda Kwenguva Yakareba kweCD19 CAR T-Cell Therapy muKurapa Yakadzokazve / Refractory Acute Lymphoblastic Leukemia
Chidzidzo chepasi chinoratidza kubudirira kwenguva refu kweCD19 CAR T-cell therapy mukurapa varwere vane relapsed/refractory acute lymphoblastic leukemia (ALL) zvichitevera allogeneic hematopoietic stem cell transplantation, ichipa tariro itsva muhematology.
Kubudirira Kufambira mberi muMuurayi Wepanyama (NK) Masero Anopfuura 50 Makore
Kwemakumi mashanu emakore apfuura, tsvakiridzo yeMasikirwo Muurayi (NK) masero akashandura manzwisisiro edu ekusagadzikana kwemukati, achipa nzira nyowani dzegomarara nehutachiona.
Kubudirira muPediatric Autoimmune Disease: CAR-T Cell Therapy Inorapa Lupus Murwere
Chidzidzo chekupayona paErlangen University Hospital zvakabudirira kubata musikana wemakore gumi nematanhatu ane chirwere chakanyanya systemic lupus erythematosus (SLE) achishandisa CAR-T cell therapy. Izvi zvinoratidza kushandiswa kwekutanga kwekurapa uku kwevana lupus, zvichipa tariro nyowani kuvana vane autoimmune zvirwere.
Kuvandudza Kubudirira kwePROTAC: Chidzidzo Chinoputsa
Ongororo ichangoburwa muNature Communications inoratidza nzwisiso yakakosha mukati memukati mekusaina nzira dzinogadzirisa kushanda kwekwakanangwa kuderedzwa kweprotein uchishandisa PROTACs. Kuwanikwa uku kunogona kugadzira nzira yekurapa kwakanyanya kwegomarara nezvimwe zvirwere.
Kukurudzira Hutano uye Kupora: Kuchengeta Kwezuva Nezuva Kwevarwere veLeukemia
Kuve nechokwadi chekuchengetedza uye kugadzika chiitiko chekurapa kwevarwere veleukemia kunosanganisira kungwarira kwezuva nezuva, kusanganisira hutsanana kwezvakatipoteredza, hutsanana hwemunhu, chikafu, uye kurovedza muviri kwakakodzera. Gwaro iri rinopa matipi akakosha ekutarisira kwakanaka kwezuva nezuva kutsigira kupora.
Groundbreaking Mibairo yeCD7-Targeted CAR-T Therapy yeT-ALL neT-LBL
Ongororo ichangoburwa inoratidza mhedzisiro inovimbisa yeCD7-targeted chimeric antigen receptor (CAR) T cell therapy mukurapa varwere vane relapsed kana refractory T-cell acute lymphoblastic leukemia (T-ALL) uye T-cell lymphoblastic lymphoma (T-LBL).
Kuvharidzirwa kwe2024 ASH Musangano Wepagore uye Kuratidzwa
Musangano Wepagore wechimakumi matanhatu nenhanhatu weAmerican Society of Hematology (ASH) uchaitwa kubva muna Zvita 7-10, 2024, paSan Diego Convention Center, ichiratidza tsvakiridzo yepasi uye kufambira mberi muhematology.
Tariro Itsva muCancer Kurapa: TILs Therapy Inobuda seInotevera Frontier
Pasinei nematambudziko arikuenderera mberi mumaindasitiri nekutengeserana, zvipimo zveCAR-T kurapwa zviri kugadziriswa nenzira itsva inovimbisa: Tumor-Infiltrating Lymphocyte (TIL) therapy. Kubudirira uku kunozivisa nguva itsva mukurwisa mamota akasimba.
Ko Maserura Therapies Ndiwo Remangwana reAutoimmune Disease?
Kurapa kwechimurenga kwegomarara kunogona zvakare kurapa nekugadzirisa zvakare immune system kuti ipe kuregererwa kwenguva refu kana kurapa zvimwe zvirwere zve autoimmune.
